- Oncology - Medical
Dr. Paul White was born in Spokane, Washington, and is the grandson of a small-town family physician in Newport, Washington. After earning his Bachelor of Science in cellular and molecular biology at the University of Washington, he worked in a small pharmaceutical company in Seattle. He quickly got bored of the monotony of laboratory science and he moved to Belfast, Northern Ireland to do volunteer work at a presbyterian church. There, he met his future wife, Kathryn, and decided to stay and study medicine at the National University College Cork. He returned to the United States to complete his residency at MetroHealth Medical Center in Cleveland, Ohio, and his Oncology training at Boston Medical Center.
Dr. White works closely with his patients to understand their lives beyond their medical diagnoses. He takes the time to understand what is important to them and to provide comprehensive, compassionate care that will meet their physical, mental and emotional needs. Although he treats a variety of oncology (cancer) and hematologic (blood) conditions, he has special interest in cancers of the blood and lymph nodes.
Dr. White and his wife have two young boys. You’ll often find them playing in local parks or cheering at soccer games. He also enjoys running and going to concerts.
Fillmore, N. R., Yellapragada, S. V., Ifeorah, C., Mehta, A., Cirstea, D., White, P. S., … & Munshi, N. C. (2019). With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood, The Journal of the American Society of Hematology, 133(24), 2615-2618.
White, P. S., Pudusseri, A., Lee, S. L., & Eton, O. (2017). Intermittent dosing of dabrafenib and trametinib in metastatic BRAFV600E mutated papillary thyroid cancer: two case reports. Thyroid, 27(9), 1201-1205.
Bae, E., White, P., Brophy, M., Lichtman, M., Krathen, M. S., & Mahalingam, M. (2017). Cutaneous Rosai–Dorfman disease with linear lesions and monoclonal gammopathy. The American Journal of Dermatopathology, 39(10), 776-781.
White, P. S., Phull, P., Brauneis, D., Sloan, J. M., Quillen, K., Sarosiek, S., & Sanchorawala, V. (2018). High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplantation, 53(12), 1593-1595.
Bruno, D.S.; White, P.S.; Thompson, C.L.; Adebisi, M.; Berger, N.A. Lipid profile and breast cancer characteristics: A retrospective correlational study. J. Clin. Oncol. 2015, 33, e12659.
White, P. S., Dennis, M., Jones, E. A., Weinberg, J. M., & Sarosiek, S. (2020). Risk Factors for Development of Hypocalcemia in Patients With Cancer Treated With Bone-Modifying Agents. Journal of the National Comprehensive Cancer Network, 18(4), 420-427.
Gupta, V. K., White, P. S., Brauneis, D., Shelton, A. C., Quillen, K., Sanchorawala, V., … & Sloan, J. M. (2019). Safety of autologous stem cell transplantation in patients with known Human T‐cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. American Journal of Hematology, 94(12), E317-E319.
Elias R, Pudusseri A, Akinboro O, White PS, Sarosiek S. Ibrutinib: a post-marketing safety analysis. J Clin Oncol. 2018;36:e19559-e.
Societies and Positions Held
MetroHealth Medical Center
Boston Medical Center
American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Oncology, Medical
American Board of Internal Medicine - Hematology